Extended benefit from sequential administration of docetaxel after standard fluorouracil, epirubicin, and cyclophosphamide regimen for node-positive breast cancer: the 8-year follow-up results of the UNICANCER-PACS01 trial
对于淋巴结阳性乳腺癌，在接受标准氟尿嘧啶、表柔比星和环磷酰胺方案治疗后序贯使用多西他赛可延长疗效：UNICANCER-PACS01试验的8年随访结果
期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2011-0442
Coudert, Bruno; Asselain, Bernard; Campone, Mario; Spielmann, Marc; Machiels, Jean-Pascal; Pénault-Llorca, Frédérique; Serin, Daniel; Lévy, Christelle; Romieu, Gilles; Canon, Jean-Luc; Orfeuvre, Hubert; Piot, Gilles; Petit, Thierry; Jerusalem, Guy; Audhuy, Bruno; Veyret, Corinne; Beauduin, Marc; Eymard, Jean-Christophe; Martin, Anne-Laure; Roché, Henri
